Director Nancy Hasley Notices Sale of 270,000 Shares (~$5.37M) Near 52-Week High
ARX has more than doubled off its 52-week low of $9.18.
Summary
Director Nancy Hasley filed notice to sell 270,000 shares (~$5.37M) of founder stock, after 20,489 shares already sold under a 10b5-1 plan for $400,838.72. The notice lands with the stock near its 52-week high and the $20.25-per-share Thoma Bravo buyout pending.
Key Events · Ownership and Investor Activity · ARX
-
Director Notices 270,000-Share Sale
Nancy Hasley filed a Form 144 to sell 270,000 common shares with an aggregate market value of $5,367,681.00 through Morgan Stanley Smith Barney.
-
Founder Stock, Prior 10b5-1 Sales
The shares are founder stock acquired 07/23/2025; 20,489 shares were already sold on 08/13/2026 for gross proceeds of $400,838.72 under a 10b5-1 plan.
-
Sale Near 52-Week High
The notice comes with the stock at $19.85, just below its 52-week high of $19.91, and near the $20.25-per-share cash price in the pending Thoma Bravo acquisition.
-
Buyout Vote Pending
The preliminary proxy filed 2026-10-30 sets a special meeting on the $20.25-per-share cash sale to Thoma Bravo; this notice does not alter those terms.
Analysis · ARX · Finance
A director is proposing to sell 270,000 shares worth roughly $5.37M — a meaningful disposition from an insider, filed the same day as the notice and with the stock trading near its 52-week high of $19.91. The sale is tied to founder stock acquired in July 2025 and follows 20,489 shares already sold under a 10b5-1 plan for $400,838.72. With the company's $20.25-per-share cash sale to Thoma Bravo pending and a special meeting set by the preliminary proxy filed 2026-10-30, insider selling into the deal price is worth noting but is not a change to the transaction terms.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ARX was trading at $19.85 on NYSE in the Finance sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $9.18 to $19.91. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.